Lupus Science & Medicine

Lupus Science & Medicine February 2016 • Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products

View Publication
Lupus Science & Medicine

Lupus Science & Medicine November 2014 • Cell-Bound Complement Activation Products in Systemic Lupus Erythematosus: Comparison with Anti-Double-Stranded DNA and Standard Complement Measurements.

View Publication
Lupus Science & Medicine

Lupus Science & Medicine September 2014 • Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements

View Publication
Rheumatology News

Rheumatology News November 2013 • Diagnosis of Lupus in the New Age of Biomarkers: Part II- New and Emerging Biomarker Technology in the Diagnosis of Lupus

View Publication
Rheumatology News

Rheumatology News September 2013 • Diagnosis of Lupus in the New Age of Biomarkers: Part I- Meeting Diagnostic Challenges in Lupus with Cell-Bound Complement Activation Products

View Publication
Arthritis Rheum

Arthritis Rheum 2013 • An Assay Panel Combining Cell-Bound Complement Activation Products With Autoantibodies to Extractable Nuclear Antigens and Mutated Citrullinated Vimentin Helps With the Differential Diagnosis of Systemic Lupus Erythematosus,

View Publication
Arthritis Rheum

Arthritis Rheum December 2012 • Measurement of Cell-Bound Complement Activation Products Enhances Diagnostic Performance in Systemic Lupus Erythematosus

View Publication
Arthritis Rheum

Arthritis Rheum 2006 • Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis

View Publication
Ann Rheum Dis

Ann Rheum Dis 2005 • Pharmacogenetic and metabolite measurements are associated with clinical status in patients with rheumatoid arthritis treated with methotrexate: results of a multicentred cross sectional observational study

View Publication
Arthritis Rheum; ; 50(9):2766-2774

Arthritis Rheum; ; 50(9):2766-2774 2004 • Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis

View Publication
Scroll to Top